5 Must-Know Marketing Moves for an Uncertain Economy

Why Playing It Safe May Be the Riskiest Move

When marketing budgets tighten and investor scrutiny intensifies, many life sciences companies are tempted to hit the brakes on marketing. But history and hard data tell us that the brands that invest strategically during economic uncertainty are the ones that come out ahead.

At BTS Consulting, we have worked with diagnostics, MedTech, pharma, and Healthtech companies for 15 years, navigating high-stakes go-to-market decisions. Here’s what we’ve learned about product commercialization and marketing budgets in today’s environment and how to make your marketing spend work harder than ever.

1. Don’t Disappear. Refocus.

Going quiet during a downturn may feel fiscally responsible, but it has unintended consequences. A landmark analysis by Harvard Business Review found that companies that maintain or increase marketing activity during recessions outperform competitors by 256% in post-recession sales growth.¹

Instead of slashing marketing budgets, reallocate. Focus on:

• Messaging that speaks to today’s buyer: think outcomes, ROI, and efficiency.
• Content that builds trust and nurtures leads over time.
• Channels that offer measurable return—SEO/AEO/AIO, LinkedIn, and account-based marketing.
• Inbound marketing which attracts motivated buyers than less focused outbound marketing campaigns.

2. Make Every Message Count

In a risk-averse climate, your buyers whether clinicians, payers, or procurement leaders need crystal-clear value. They become more price-sensitive and gravitate towards a sure thing rather than swing for the fences. A McKinsey report found that 77% of B2B decision-makers now say that messaging clarity is a critical factor in their purchasing decisions.²

What is message clarity, and how do you attain it? It is simply identifying a specific problem faced by a prospect and how you provide a solution that will improve their bottom line or patient outcomes.

Simplified messaging around:

• Early detection and prevention to avoid costly interventions
• Cost containment for value-based organizations
• Workflow efficiency for overburdened clinicians
• Patient retention and satisfaction for private equity–backed provider groups

…consistently outperforms complex, jargon-heavy approaches.

3. Prove Value with Smart Content

80% of buyers make their purchasing decision before ever talking to a sales rep.³ That makes solution-oriented, ROI-focused content more essential than ever.

To stand out, create assets that:

• De-risk decision-making (e.g., white papers, validation data)
• Provide social proof (e.g., case studies, testimonials)
• Emphasize measurable clinical and financial outcomes

In uncertain times, your content must shift from “awareness” to “confidence.”

4. Shorten the Path to Conversion

Prospects are busier, more skeptical about uncorroborated claims, and accountable to more stakeholders. You can’t afford a leaky funnel or a bloated buyer journey.

Optimize by:

• Creating persona-specific landing pages
• Using data-backed calls to action (e.g., “See how XYZ reduced unnecessary referrals by 34%”)
• Offering tools like ROI calculators, guided demos, and diagnostic checklists

Small tweaks to conversion paths can yield an outsized impact in a cautious economy.

5. Partner with Specialists Who Understand Your Science and Your Market

When marketing budgets are constrained, you can’t afford the “agency learning curve.” You need a marketing partner who gets your technology and your buyers.

At BTS Consulting, we’re more than marketers. We’re former scientists and strategists who have launched diagnostic tests, genomic profiling platforms, digital health tools, and specialty pharmaceuticals. That means we can:

• Decode your innovation fast
• Translate science into differentiated messaging
• Execute with precision and speed

Final Thought: Now Is the Time to Lead

Economic uncertainty may push some companies to retreat, but bold companies see this as a golden opportunity. With focused messaging, relevant content, and the right marketing partner, your brand can emerge stronger, more trusted, and better positioned to win.

Ready to turn today’s challenges into tomorrow’s growth?
Let’s talk

References:

1. Gulati, R., Nohria, N., & Wohlgezogen, F. (2010). Roaring out of recession. Harvard Business Review. https://hbr.org/2010/03/roaring-out-of-recession
2. McKinsey & Company. (2022). The new B2B growth equation. https://www.mckinsey.com/business-functions/growth-marketing-and-sales/our-insights/the-new-b2b-growth-equation
3. Gartner. (2022). The B2B buyer’s journey: How to align your marketing to today’s behavior. https://www.gartner.com/en/articles/3-ways-to-align-b2b-marketing-with-how-customers-buy